Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

HHS to offer Tamiflu doses from national stockpile

By Brian Buntz | December 21, 2022

Tamiflu

[Image courtesy of Wikimedia Commons]

The U.S. Department of Health and Human Services (HHS) has announced that it would provide the prescription flu treatment Tamiflu (oseltamivir phosphate) to jurisdictions with an elevated demand for the antiviral during the flu season.

The move would make millions of treatment courses available.

Roche is the developer of Tamiflu. Several generics are also available for the drug.

The U.S. government stores the antiviral in its Strategic National Stockpile (SNS), containing antibiotics, life-support medications, airway maintenance supplies and other medical items.

HHS notes that jurisdictions will work with the Administration for Strategic Preparedness and Response (ASPR) regional teams, who will evaluate requests for the antiviral.

The news comes as supplies of Tamiflu have dwindled. In addition, the U.S. has also encountered shortages of the ADHD medicine Adderall and the antibiotic amoxicillin.

The CDC notes that more than 23,500 patients are currently hospitalized as a result of flu infections in the U.S.

FDA indicates Tamiflu to treat acute, uncomplicated flu infections in patients at least two weeks old who have been symptomatic for no more than two days. The agency also indicates the antiviral as prophylaxis for patients at least one year old.

Earlier in December, the ASPR loosened restrictions on the Tamiflu stockpile that limited its use for pandemic flu.

“Today we are taking action so that every jurisdiction can meet the increased demand for Tamiflu this flu season,” said HHS Secretary Xavier Becerra in a news release. “State stockpiles can be utilized, and if jurisdictions need access to the Strategic National Stockpile, they now have it to respond to the current seasonal flu outbreak.”

Tamiflu first won FDA approval in 1999 for use in adults. The agency later expanded its use to pediatric patients.

Over the years, some observers have questioned the risk-benefit ratio of Tamiflu and questioned the decisions of various international organizations to stockpile the drug based on currently available data, as an article in the Indian Journal of Pharmacology notes.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE